Literature DB >> 33118032

CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.

Jordi Galiano-Landeira1, Albert Torra1, Miquel Vila1,2,3, Jordi Bové1.   

Abstract

There is no consensus on the exact role of the adaptive immune system in Parkinson's disease pathogenesis, although there is increasing evidence that it is somehow involved. Moreover, T cell infiltration in the brain has not been thoroughly studied in Parkinson's disease and no study has assessed the infiltration in incidental Lewy body diseases cases that are considered to be early presymptomatic stages of the disease. In this study, we performed an immunohistochemistry/immunofluorescence quantitative and phenotypic assessment of T cell infiltration in human substantia nigra pars compacta and analysed the correlations with neuronal death and synucleinopathy throughout different stages of the disease. We included two groups of incidental Lewy disease in the study. One of the groups, which is believed to be the earliest stage of the disease, showed α-synuclein aggregates only in the olfactory bulb. The second group also presented α-synuclein aggregates in the substantia nigra. We also assessed the formation of different α-synuclein aggregates throughout the different stages of the unified staging system for Lewy body disorders (I to IV). We found that CD8 T cells were increased in diagnosed Parkinson's disease cases compared to the control group and their density positively correlated with neuronal death. Some of the infiltrating CD8 T cells were indeed contacting dopaminergic neurons. No differences were found regarding CD4 T cells. In the earliest stage of the disease, when substantia nigra α-synuclein aggregation is absent, we found a robust CD8 T cell infiltration and no dopaminergic neuronal death yet. Conversely, in the next stage we found neuronal loss and a milder CD8 T cell infiltration. CD8 T cell infiltration paralleled that of α-synuclein accumulation and neuronal death throughout stages II to IV. We also confirmed that CD8 T cells in charge of immune surveillance and involved in the aetiopathogenesis of the disease are equipped with cytolytic enzymes (granzyme A, B and K) and/or proinflammatory cytokines (interferon gamma), and that phenotypic differences were observed between early and late stages of the disease. We also demonstrate that a high proportion of nigral CD8 T cells are tissue resident memory T cells. Our results show that nigral cytotoxic CD8 T cell infiltration is an earlier pathogenic event than α-synuclein aggregation and neuronal death and that it parallels the progression of neuronal death and synucleinopathy in Parkinson's disease. Overall, our study suggests that CD8 T cell cytotoxic attack may initiate and propagate neuronal death and synucleinopathy in Parkinson's disease.
© The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Parkinson’s disease; cytotoxic T lymphocyte; incidental Lewy body disease; tissue resident memory T cells; α-synuclein

Year:  2020        PMID: 33118032     DOI: 10.1093/brain/awaa269

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  25 in total

Review 1.  Age-Related Adaptive Immune Changes in Parkinson's Disease.

Authors:  Antonina Kouli; Caroline H Williams-Gray
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 2.  Neuroinflammation and Immune Changes in Prodromal Parkinson's Disease and Other Synucleinopathies.

Authors:  Miriam Højholt Terkelsen; Ida H Klaestrup; Victor Hvingelby; Johanne Lauritsen; Nicola Pavese; Marina Romero-Ramos
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 3.  Age-Related Midbrain Inflammation and Senescence in Parkinson's Disease.

Authors:  Taylor Russo; Markus Riessland
Journal:  Front Aging Neurosci       Date:  2022-06-02       Impact factor: 5.702

Review 4.  Neuroinflammation in Parkinson's Disease - Putative Pathomechanisms and Targets for Disease-Modification.

Authors:  Alexander Grotemeyer; Rhonda Leah McFleder; Jingjing Wu; Jörg Wischhusen; Chi Wang Ip
Journal:  Front Immunol       Date:  2022-05-18       Impact factor: 8.786

Review 5.  T Lymphocytes in Parkinson's Disease.

Authors:  Elena Contaldi; Luca Magistrelli; Cristoforo Comi
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 6.  Immunogenetic Determinants of Parkinson's Disease Etiology.

Authors:  Pin-Jui Kung; Inas Elsayed; Paula Reyes-Pérez; Sara Bandres-Ciga
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 7.  Fundamental mechanistic insights from rare but paradigmatic neuroimmunological diseases.

Authors:  Heinz Wiendl; Catharina C Gross; Jan Bauer; Doron Merkler; Alexandre Prat; Roland Liblau
Journal:  Nat Rev Neurol       Date:  2021-05-28       Impact factor: 42.937

8.  Profiling Inflammatory Extracellular Vesicles in Plasma and Cerebrospinal Fluid: An Optimized Diagnostic Model for Parkinson's Disease.

Authors:  Elena Vacchi; Jacopo Burrello; Alessio Burrello; Sara Bolis; Silvia Monticone; Lucio Barile; Alain Kaelin-Lang; Giorgia Melli
Journal:  Biomedicines       Date:  2021-02-25

Review 9.  Hot Topics in Recent Parkinson's Disease Research: Where We are and Where We Should Go.

Authors:  Song Li; Congcong Jia; Tianbai Li; Weidong Le
Journal:  Neurosci Bull       Date:  2021-07-27       Impact factor: 5.203

Review 10.  New Avenues for Parkinson's Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota.

Authors:  Marina Lorente-Picón; Ariadna Laguna
Journal:  Biomolecules       Date:  2021-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.